BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2
18 results:

  • 1. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    Mehra T; Lupatsch JE; Kössler T; Dedes K; Siebenhüner AR; von Moos R; Wicki A; Schwenkglenks ME
    PLoS One; 2024; 19(4):e0301271. PubMed ID: 38573891
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids.
    Wang C; Chen L; Sun Y; Guo W; Taouil AK; Ojima I
    Bioorg Chem; 2022 Feb; 119():105578. PubMed ID: 34979464
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CASK regulates Notch pathway and functions as a tumor promoter in pancreatic cancer.
    Qu J; Zhou Y; Li Y; Yu J; Wang W
    Arch Biochem Biophys; 2021 Apr; 701():108789. PubMed ID: 33548214
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH
    Wang C; Wang X; Sun Y; Taouil AK; Yan S; Botchkina GI; Ojima I
    Bioorg Chem; 2020 Jan; 95():103523. PubMed ID: 31911305
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pancreatic involvement by mesenchymal chondrosarcoma harboring the hey1-NCOA2 gene fusion.
    Cohen JN; Solomon DA; Horvai AE; Kakar S
    Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer.
    Bailey JM; Alsina J; Rasheed ZA; McAllister FM; Fu YY; Plentz R; Zhang H; Pasricha PJ; Bardeesy N; Matsui W; Maitra A; Leach SD
    Gastroenterology; 2014 Jan; 146(1):245-56. PubMed ID: 24096005
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
    Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
    Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.
    Yabuuchi S; Pai SG; Campbell NR; de Wilde RF; De Oliveira E; Korangath P; Streppel MM; Rasheed ZA; Hidalgo M; Maitra A; Rajeshkumar NV
    Cancer Lett; 2013 Jul; 335(1):41-51. PubMed ID: 23402814
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.
    Mann CD; Bastianpillai C; Neal CP; Masood MM; Jones DJ; Teichert F; Singh R; Karpova E; Berry DP; Manson MM
    PLoS One; 2012; 7(12):e51119. PubMed ID: 23226563
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway.
    Wang H; Chen Y; Fernandez-Del Castillo C; Yilmaz O; Deshpande V
    Mod Pathol; 2013 Jan; 26(1):139-47. PubMed ID: 22918166
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
    Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
    J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas.
    Cavard C; Audebourg A; Letourneur F; Audard V; Beuvon F; Cagnard N; Radenen B; Varlet P; Vacher-Lavenu MC; Perret C; Terris B
    J Pathol; 2009 Jun; 218(2):201-9. PubMed ID: 19235837
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lack of nuclear expression of hairy and enhancer of split-1 (HES1) in pancreatic endocrine tumors.
    Johansson T; Lejonklou MH; Ekeblad S; Stålberg P; Skogseid B
    Horm Metab Res; 2008 May; 40(5):354-9. PubMed ID: 18491256
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, hey1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
    Katoh M; Katoh M
    Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
    Katoh M; Katoh M
    Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparative genomics on HHIP family orthologs.
    Katoh Y; Katoh M
    Int J Mol Med; 2006 Feb; 17(2):391-5. PubMed ID: 16391842
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma.
    Lucas B; Grigo K; Erdmann S; Lausen J; Klein-Hitpass L; Ryffel GU
    Oncogene; 2005 Sep; 24(42):6418-31. PubMed ID: 16007190
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.